Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.20.4
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]        
Revenues $ 4,936 $ 4,395 $ 16,472 $ 13,616
Cost of revenues 2,941 2,394 9,719 7,147
Gross profit 1,995 2,001 6,753 6,469
Operating expenses        
Research and development 33 248 425 856
Selling, general and administrative 2,100 2,861 6,963 9,779
Total operating expenses 2,133 3,109 7,388 10,635
Loss from operations (138) (1,108) (635) (4,166)
Interest expense (5) (1) (12) (13)
Interest income 3 33 14 117
Other (expense) income, net (490) (134) (687) (234)
Gain on sale of assets 4 0 137 2,472
Loss from continuing operations (626) (1,210) (1,183) (1,824)
Income (loss) from discontinued operations (Note 4) (24) 126 893 252
Net loss $ (650) $ (1,084) $ (290) $ (1,572)
Net income (loss) per share: basic and diluted        
Continuing operations $ (0.31) $ (0.81) $ (0.60) $ (1.32)
Discontinued operations: (0.01) 0.09 0.45 0.18
Net income (loss) per share: basic and diluted $ (0.32) $ (0.72) $ (0.15) $ (1.14)
Weighted-average number of shares used in per common share calculations: basic and diluted 2,052 1,500 1,967 1,378
Other comprehensive income (loss)        
Net loss $ (650) $ (1,084) $ (290) $ (1,572)
Foreign currency translation adjustments 1,020 264 1,375 168
Comprehensive income (loss) $ 370 $ (820) $ 1,085 $ (1,404)